LoginRegister
    Natco Pharma settles patent litigation over generic version of anti-cancer drug KyprolisNatco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis
    Sun Pharma Whole Time Director Sudhir Valia steps down from executive roleSun Pharma Whole Time Director Sudhir Valia steps down from executive role
    Addressable medicine market for e-pharmacies in India likely to reach $18.1 billion by 2023: ReportAddressable medicine market for e-pharmacies in India likely to reach $18.1 billion by 2023: Report
    ResMed appoints Shubhi Khurana as New India, South Asia General Manager; to help increase awareness about sleep apneaResMed appoints Shubhi Khurana as New India, South Asia General Manager; to help increase awareness...
    Cadila Healthcare posts Q4 net profit of Rs 460 croreCadila Healthcare posts Q4 net profit of Rs 460 crore
    Misleading information on vaccines should be taken down from social media: Vaccine ChiefMisleading information on vaccines should be taken down from social media: Vaccine Chief
    Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licenceRessurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence
    Sun Pharma Q4 profit falls by half to Rs 636 crore due to change in distribution strategySun Pharma Q4 profit falls by half to Rs 636 crore due to change in distribution strategy
    Medikabazaar to raise Rs 200 crore in Series B fundingMedikabazaar to raise Rs 200 crore in Series B funding
    Mallinckrodt Amitiza to stay with branded business after spin-offMallinckrodt Amitiza to stay with branded business after spin-off
    Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiverTechnical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical...
    Manufacturers illegally marketing unauthorized diabetes management devices; USFDA issues warningManufacturers illegally marketing unauthorized diabetes management devices; USFDA issues warning
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X